Search
for
Sort by
Research 211–240 of 1000+
- Effect of Zinc-Deficient Diet on Two Strains of Mice
- Structure, Function and Application of <i>Tremella Fuciformis</i> Polysaccharide: A Review
- Resolution of Waldenström's macroglubulinemia related isolated neutropenia by immunochemotherapy
- Flavonoid 4,4′-dimethoxychalcone selectively eliminates senescent cells via activating ferritinophagy
- Plant-derived exosome-like nanovesicles: a novel therapeutic perspective for skin diseases
- <i>Malus pumila</i> Mill. cv Annurca apple extract might be therapeutically useful against oxidative stress and patterned hair loss
- Celiac Disease: Beyond Diet and Food Awareness
- Topical drug delivery strategies for enhancing drug effectiveness by skin barriers, drug delivery systems and individualized dosing
- Hollow polydopamine nanoparticles loading with peptide RL-QN15: a new pro-regenerative therapeutic agent for skin wounds
- Microneedle Arrays Combined with Nanomedicine Approaches for Transdermal Delivery of Therapeutics
- Vitamin A toxicity: When one a day doesn't keep the doctor away
- Infrared and Raman Diagnostic Modeling of Phosphate Adsorption on Ceria Nanoparticles
- Lipid Droplets from Plants and Microalgae: Characteristics, Extractions, and Applications
- Facile General Injectable Gelatin/Metal/Tea Polyphenol Double Nanonetworks Remodel Wound Microenvironment and Accelerate Healing
- Bioprinted Recombinant Human-Collagen-Based In Vitro Skin Models for Assessing Effects of Nano-ZnO on Dermis
- Prevalence of Cobalt in the Environment and Its Role in Biological Processes
- Biochemistry of Vitamin B: Metabolic Regulations, Deficiency Disorders and Emerging Therapeutic Strategies
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Can nanozymes make the leap to the clinic? Advances, hurdles, and prospects
- Sinapic acid and glabridin synergistically mitigate androgenetic alopecia by modulating ferroptosis through stabilization of β-catenin against ubiquitin-dependent degradation.
- Research Progress on the Immunomodulatory Effects by Dang Gui (Radix Angelica sinensis) and Its Active Chemical Components
- Hyperandrogenism and insulin resistance modulate gravid uterine and placental ferroptosis in PCOS-like rats
- Long-Term Administration of Triterpenoids From Ganoderma lucidum Mitigates Age-Associated Brain Physiological Decline via Regulating Sphingolipid Metabolism and Enhancing Autophagy in Mice
- Immunosenescence and inflammaging in Parkinson’s disease: mechanisms and therapeutic prospects
- Schizochytrium sp. Extracted Lipids Prevent Alopecia by Enhancing Antioxidation and Inhibiting Ferroptosis of Dermal Papilla Cells
- Oxidative Stress and Skin Diseases: The Role of Lipid Peroxidation
- Recent Advances in the Electro-Active Therapeutic Phytochemical-Based Sensors
- Reactive Oxygen Species (ROS): Beneficial Companions of Plants’ Developmental Processes
- All‐Natural Immunomodulatory Bioadhesive Hydrogel Promotes Angiogenesis and Diabetic Wound Healing by Regulating Macrophage Heterogeneity